1Distler M,Pilarsky E,Kersting S,et al. PreoperativeCEA and CA 19-9 are prognostic markers for survivalafter curative resection for ductal adenocarcinoma of thepancreas - a retrospective tumor marker prognostic study[J].Int J Surg,2013,11(10):1067.
2Cwik G,Wallner G,Skoczylas T,et al. Cancer antigens19-9 and 125 in the differential diagnosis of pancreaticmass lesions[J]. Arch Surg,2006,141(10):968.
3Einama T,Kamachi H,Nishihara H,et al. Co-expressionof mesothelin and CA125 correlates with unfavorable patientoutcome in pancreatic ductal adenocarcinoma[J]. Pancreas,2011,40(8):1276.
